# Outcomes of Intravitreal Ranibizumab Injection for Diabetic Vitreous Hemorrhage

> **NCT07690800** · PHASE4 · COMPLETED · sponsor: **Benha University** · enrollment: 30 (actual)

## Conditions studied

- Diabetic Vitreous Hemorrhage
- Intravitreal Injections
- Ranibizumab

## Interventions

- **DRUG:** Ranibizumab

## Key facts

- **NCT ID:** NCT07690800
- **Lead sponsor:** Benha University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-04-01
- **Primary completion:** 2026-03-31
- **Final completion:** 2026-04-01
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2026-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07690800

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07690800, "Outcomes of Intravitreal Ranibizumab Injection for Diabetic Vitreous Hemorrhage". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07690800. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*